Ranibizumab biosimilar(PlantForm Corporation)

N/A

Report date: 2025/03/07 17:34:42

Base Information

Drug NameRanibizumab biosimilar(PlantForm Corporation)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Biosimilar

Mechanisms of ActionVascular endothelial growth factor A inhibitors

TargetsVascular endothelial growth factor A

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPlantForm Corp

China Registration ClassN/A

Active CompaniesPlantForm Corp

Inactive CompaniesN/A

Active IndicationsMacular Degeneration

Inactive IndicationsN/A

ATC CodeN/A